Advertisement

Reactions Weekly

, Volume 1714, Issue 1, pp 2–2 | Cite as

Ibrutinib linked to serious ventricular tachyarrhythmia?

News item
  • 22 Downloads

Reference

  1. Government of Canada. Summary Safety Review - IMBRUVICA (ibrutinib) - Assessing the potential risk of a serious and life-threatening abnormal heart rhythm (ventricular tachyarrhythmia). Internet Document : 26 Jul 2018. Available from: URL: https://hpr-rps.hres.ca/reg-content/summary-safety-review-detail.php?lang=en&linkID=SSR00206

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations